CEO Leaders Panel

Time: 9:15 am
day: Day One


With CAR-T therapies now on the market and spreading globally for approval, what does the future hold and what are the next steps to ensure these, and future adoptive immunotherapies reach all patients in need? Spend an hour with this unique panel of CEOs and company executives from leading CAR-TCR developers to better understand strategic challenges and future priorities for the next generation CAR-T and TCR cell therapy development